inhibitor | OA JF

Sat. Mar 25th, 2023

Eosinophil as a biomarker for diagnosis, prediction, and prognosis evaluation of severe checkpoint inhibitor pneumonitis

Yanlin Li, et al.

Frontiers | Eosinophil as a biomarker for diagnosis, prediction, and prognosis evaluation of severe…

Radiofluorination of a highly potent ATM inhibitor as a potential PET imaging agent – EJNMMI Research

Aug 13, 2022 Claudia Rose Fraser, Javier Ajenjo, Mathew Veal, Gemma Marie Dias, Chung Chan, Edward O’Neill, Gianluca Destro, Doreen Lau, Anna Pacelli, Veronique Gouverneur, Rebekka Hueting and Bart Cornelissen

Chemical synthesis The synthesis of the non-radioactive 19F version of compound 1 followed methods reported by patent [8], with minor modifications as detailed in the supporting information (Fig. 2; Additional file…

Frontiers

Nano-Chemotherapy synergize with immune checkpoint inhibitor- A better option?

Xinye Qian, et al.

Aug 10, 2022 Xinye Qian

Frontiers | Nano-Chemotherapy synergize with immune checkpoint inhibitor- A better option? …

Frontiers

TNF-α inhibitor ameliorates immune-related arthritis and pneumonitis in humanized mice

Jian Gao, et al.

Aug 9, 2022 Jian Gao

Frontiers | TNF-α inhibitor ameliorates immune-related arthritis and pneumonitis in humanized mice …

Frontiers

Baduanjin’s impact on quality of life and sleep quality in breast cancer survivors receiving aromatase inhibitor therapy: a randomized controlled trial

Jingwen Liao, et al.

Aug 7, 2022 Jingwen Liao

Frontiers | Baduanjin’s impact on quality of life and sleep quality in breast cancer survivors…

Frontiers

Radiosynthesis and First Preclinical Evaluation of the Novel 11C-Labeled FAP Inhibitor 11C-FAPI: A Comparative Study of 11C-FAPIs and (68Ga) Ga-DOTA-FAPI-04 in a High–FAP-Expression Mouse Model

Cheng Wang, et al.

Aug 6, 2022 Cheng Wang

Frontiers | Radiosynthesis and First Preclinical Evaluation of the Novel 11C-Labeled FAP Inhibitor 11C-FAPI: A…

Frontiers

The F1Fo-ATPase inhibitor protein IF1 in pathophysiology

Cristina Gatto, et al.

Aug 4, 2022 Cristina Gatto

Frontiers | The F1Fo-ATPase inhibitor protein IF1 in pathophysiology …

Frontiers

Structural-Guided Identification of Small Molecule Inhibitor of UHRF1 Methyltransferase Activity

Md Abdul Awal, et al.

Aug 3, 2022 Md Abdul Awal

Frontiers | Structural-Guided Identification of Small Molecule Inhibitor of UHRF1 Methyltransferase Activity …

Frontiers

What Plasma Can Tell Us When Tissue Cannot: A Case Report of Genomic Testing in mCRPC and Clinical Response to Treatment With the PARP Inhibitor Rucaparib

Daniel P. Petrylak, et al.

Aug 1, 2022 Daniel P. Petrylak

Frontiers | What Plasma Can Tell Us When Tissue Cannot: A Case Report of Genomic…

Springer Open

Toward in vivo proof of binding of 18F-labeled inhibitor [18F]TRACK to peripheral tropomyosin receptor kinases – EJNMMI Research

Jul 30, 2022 Melinda Wuest, Justin J. Bailey, Jennifer Dufour, Darryl Glubrecht, Vanessa Omana, Tom H. Johnston, Jonathan M. Brotchie and Ralf Schirrmacher

Vaishnavi A, Le AT, Doebele RC. TRKing down an old oncogene in a new era of targeted therapy. Cancer Discov. 2015;5:25–34. CAS PubMed Article Google Scholar Amatu A, Sartore-Bianchi A,…